Mon. 25 Mar 2024, 4:28pm ET
Benzinga
Earnings, News
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 15.38 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $243.97 thousand which missed the analyst consensus estimate of $450.00 thousand by 45.78 percent. This is a 103.79 percent increase over sales of $119.72 thousand the same period last year.